Arem Pacific Corporation

ARPC

Medical - Care Facilities · Healthcare

Price

$0.00

+0.00 (+0.00%)

Market Cap

$336,555

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Share count rising — dilution

+11.8% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 334.6M (2019) → 374.0M (2023)

Arem Pacific Corporation is a small healthcare company focused on providing medical and wellness services. It operates in the medical care facilities space, meaning it runs or supports facilities where patients receive health-related treatment or care. The company targets individual patients and healthcare consumers, primarily in markets connected to the Asia-Pacific region.

Arem Pacific generates revenue by delivering healthcare services directly to patients, which explains its relatively high gross margin of nearly 70%. However, the company is currently unprofitable at the operating level and earns a negative return on invested capital, suggesting it spends more running the business than it currently brings in. It is a very small company with a market cap near zero, which means it carries significant risks around financial stability, access to capital, and the ability to scale its operations enough to reach consistent profitability — that remains the central challenge the business must overcome.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-18.7% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+100.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

26.9%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~21 months

$46,705 cash & investments

Adequate runway but may need to raise capital within 2 years

Revenue declining

Arem Pacific Corporation's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

56.8%

Premium pricing power — 56.8% gross margin

Operating Margin

-10.7%

Losing money on operations — -10.7%

ROCE

-112.6%

Weak — -112.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+0.5%

Nearly flat sales (0.5% YoY)

EPS YoY

-248.0%

Earnings shrinking (-248.0% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-59.7%

Burning cash (-59.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial